---
title: "Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301408.SZ.md"
symbol: "301408.SZ"
name: "Anhui Huaren Health Pharmaceutical Co., Ltd."
industry: "Drug Retail"
datetime: "2026-05-20T09:04:31.985Z"
locales:
  - [en](https://longbridge.com/en/quote/301408.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301408.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301408.SZ.md)
---

# Anhui Huaren Health Pharmaceutical Co., Ltd. (301408.SZ)

## Company Overview

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products.

| Item | Detail |
|------|--------|
| Industry | Drug Retail |
| Exchange | CN Market |
| Website | [www.hrjkjt.com](https://www.hrjkjt.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.31)**

**Industry**: Drug Retail

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 8 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.17% |  |
| Net Profit YoY | 38.59% |  |
| P/B Ratio | 3.40 |  |
| Dividend Ratio | 0.54% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7417354964.86 |  |
| Revenue | 5650853686.22 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.87% | B |
| Profit Margin | 3.71% | C |
| Gross Margin | 35.14% | C |
| Revenue YoY | 20.17% | B |
| Net Profit YoY | 38.59% | B |
| Total Assets YoY | 12.12% | B |
| Net Assets YoY | 5.56% | C |
| Cash Flow Margin | 371.60% | A |
| OCF YoY | 20.17% | B |
| Turnover | 1.07 | A |
| Gearing Ratio | 59.58% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Anhui Huaren Health Pharmaceutical Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.17%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "38.59%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.40",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.54%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7417354964.86",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5650853686.22",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.87%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "3.71%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "35.14%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "20.17%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "38.59%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.12%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.56%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "371.60%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "20.17%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.07",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "59.58%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 35.35 | 7/8 | 41.65 | 37.63 | 32.04 |
| PB | 3.40 | 9/8 | 3.78 | 2.97 | 2.55 |
| PS (TTM) | 1.31 | 9/8 | 1.52 | 1.27 | 1.06 |
| Dividend Yield | 0.54% | 7/8 | 0.75% | 0.65% | 0.50% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Yifeng Pharmacy (603939.SH) | B | C | B | C | C | B |
| 02 | DSL (603233.SH) | B | C | A | D | B | B |
| 03 | Huaren Health (301408.SZ) | B | B | A | D | A | B |
| 04 | SYPM (301017.SZ) | C | B | A | E | A | B |
| 05 | NO.1 PHARMACY (600833.SH) | C | C | A | C | C | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301408.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301408.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301408.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301408.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**